Simplex Trading’s Juniper Pharmaceuticals, Inc. Common Stock JNP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-5
Closed -$1K 8267
2018
Q1
$1K Buy
+5
New +$42 ﹤0.01% 5970
2016
Q4
Sell
-29
Closed -$4K 6982
2016
Q3
$4K Sell
29
-73
-72% -$483 ﹤0.01% 4587
2016
Q2
$12K Sell
102
-169
-62% -$1.19K ﹤0.01% 3467
2016
Q1
$35K Buy
+271
New +$1.99K ﹤0.01% 2298
2015
Q4
Sell
-40
Closed -$11K 6579
2015
Q3
$11K Buy
+40
New +$442 ﹤0.01% 3384

Simplex Trading's JNP Position: Q3 2018 in Review

Simplex Trading sold out of Juniper Pharmaceuticals, Inc. Common Stock (JNP) in Q3 2018, closing a stake of 15,474 shares — an estimated $134K sold.

Simplex Trading first reported a position in JNP in Q2 2015 and held it in 9 quarters. The position peaked at $134K in Q2 2018. 0 funds tracked by Wall St. Rank hold JNP as of Q3 2018.

  • Simplex Trading reported no remaining Juniper Pharmaceuticals, Inc. Common Stock position as of Q3 2018 after selling out during the quarter.
  • Simplex Trading sold 15,474 Juniper Pharmaceuticals, Inc. Common Stock shares in Q3 2018, an estimated $134K.
  • Simplex Trading first reported a position in Juniper Pharmaceuticals, Inc. Common Stock in Q2 2015 and held it in 9 quarters.
  • Simplex Trading's Juniper Pharmaceuticals, Inc. Common Stock position peaked at $134K in Q2 2018.
  • 0 funds tracked by Wall St. Rank held Juniper Pharmaceuticals, Inc. Common Stock as of Q3 2018.

Based on Simplex Trading's 13F filing for Q3 2018, filed 23 Oct 2018.